See the DrugPatentWatch profile for cosentyx
Does Cosentyx (secukinumab) lower your immune system?
Cosentyx can weaken parts of the immune response, because it blocks interleukin-17A (IL‑17A), a signal involved in inflammation and immune function. People taking it may be at higher risk for certain infections, which is how this immune effect shows up in real life [1][2].
What kinds of infections can increase while on Cosentyx?
The main concern is infections, particularly of the upper respiratory tract, and there are also warnings about more serious infections. If an infection develops, clinicians may pause treatment while it is treated [1][2].
Can it cause immunosuppression like steroids or transplant drugs?
It is immunomodulatory rather than broad, all-over immunosuppression like long-term corticosteroids. The risk profile is still tied to immune signaling and IL‑17A blockade, so infection risk is a key part of patient counseling [1][2].
Who should be extra careful?
People with active infections or a history of recurrent infections should discuss this before starting or continuing Cosentyx. If you develop fever, worsening illness, or symptoms of infection while on it, you should contact your healthcare team promptly [1][2].
Does Cosentyx lower white blood cell counts?
Cosentyx is not primarily known for causing the kind of blood-count suppression seen with some other immune-suppressing therapies. The more consistent safety signal is infection risk tied to immune pathway effects [1][2].
What if I’m already on other immune-lowering medicines?
Using Cosentyx alongside other immunosuppressive drugs can increase overall infection risk. Your prescriber typically weighs benefits versus infection risk based on your other medications and health history [1][2].
How to reduce risk while taking Cosentyx
Follow your clinician’s infection-monitoring plan, report infections early, and ask about vaccinations (timing and whether live vaccines are appropriate). Your prescribing clinician should guide vaccine decisions based on your specific situation [1][2].
Sources:
1. https://www.cosentyx.com/
2. https://www.accessdata.fda.gov/